@dhovekamp42 @Gambiste1 @tuduylinh @SptAdd @Adaptimmune I believe there's likely an acquisition appetite for $ADAP especially after latest milestone achieved . Of course, thr premium might be hard to digest, but some BP need a boost in a high value treatment  $PFE comes to mind